Skip to content
Friday 28 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,816.69
+0.22%
DAX
26,502.59
+0.51%
CAC 40
8,396.46
+0.92%
STOXX 50
6,468.02
+0.67%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Saturday 28 August 2021 10:47 am  |  Updated:  Friday 05 November 2021 12:55 pm

Delta Covid variant patients twice as likely to need hospital care

By: Edward Thicknesse

Add as a preferred source on Google
A new study into the Delta variant of Covid-19 suggests that those who contract the variant are twice as likely to require hospital care than those who contracted the original disease.

A new study into the Delta variant of Covid-19 suggests that those who contract the variant are twice as likely to require hospital care than those who contracted the original disease.

The findings, which were published in medical journal the Lancet, looked at cases of the disease between March and May.

However, it found that vaccination “leads to a similar relative reduction in the risk of hospitalisation for patients with the delta variant or the alpha variant”.

Experts said that the study proved why it was so important for everyone to get vaccinated against the disease.

Dr Gavin Dabrera, from Public Health England, which carried out the study, told the BBC: “We already know that vaccination offers excellent protection against Delta and, as this variant accounts for over 99 per cent of Covid cases in the UK, it is vital that those who have not received two doses of vaccine do so as soon as possible.

“It is still important that if you have Covid symptoms, stay home and get a PCR test as soon as possible.”

Scientists evaluated 43,338 Covid cases that occurred in the two month period, when both the Alpha and Delta variants were in circulation.

Most of those infected did not need hospital care, but a small proportion – 196 (2.3 per cent) of the people infected with Delta and 764 (2.2 per cent) of those with Alpha – did.

Risk of hospital admission was twice as high for individuals diagnosed with the Delta variant, compared to those with Alpha, after adjusting for differences such as age, sex and ethnicity.

The study comes as cases of Covid-19 continue to edge up in the UK, with over 38,000 cases and 100 deaths recorded yesterday.

Around 42m people, or about 78 per cent of adults, have now had two doses of a vaccine.

A recent study showed that two doses of the Pfizer vaccine had a 96 per cent effectiveness against vaccination, while for the Astrazeneca vaccine the figure is 92 per cent.

Read more

New Drill-Free Treatment Helps Patients to Feel at Ease in the Dentist Chair

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • Coronavirus

Trending Articles

  • Pensioners to hand over bank statements in government benefits crackdown

  • Jamie Carragher: HMRC petitions for Sky Sports star to be declared bankrupt

  • Brewdog founder James Watt hits out at ‘total silence’ over new venture

  • Lloyds Bank and Halifax users unable to use app in latest outage

  • Economists urge Bank of England to halt bond sales as borrowing costs climb

More from Morning Wire

  • New Drill-Free Treatment Helps Patients to Feel at Ease in the Dentist Chair

    Business Wire
  • NHS data counters claims that £330m Palantir deal has led to ‘no improvement’

    Tech
    Brit are seeking financial support from the ‘Bank of Mum and Dad’ to afford private healthcare.
  • Silence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile

    Business Wire
  • Alfasigma to Acquire Nordic Group B.V. Expanding Its Specialty Care Portfolio and Presence in Europe

    Business Wire
  • Prothena Reports Second Quarter 2026 Financial Results and Business Highlights

    Business Wire
  • Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma

    Business Wire
  • Nanochon Receives Regulatory Approval from Panamá’s Ministry of Health to Initiate First-in-Human Clinical Study of Chondrograft™

    Business Wire
  • Fanplayr Launches Catalog Intelligence, Transforming Product Catalogs into AI-Ready Product Intelligence

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook